A

Aura Biosciences
D

AURA

7.52000
USD
-0.10
(-1.31%)
مغلق
حجم التداول
11,348
الربح لكل سهم
-2
العائد الربحي
-
P/E
-4
حجم السوق
375,635,024
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    C
    CHGG
    -0.04500
    (-3.04%)
    1.43500 USD
    CRWD
    CRWD
    -29.49
    (-6.76%)
    406.64 USD
    D
    DOCU
    -2.220
    (-2.58%)
    83.950 USD
    F
    FSLY
    -0.55000
    (-7.04%)
    7.26000 USD
    PINS
    PINS
    -1.805
    (-4.56%)
    37.745 USD
    SHOP
    SHOP
    -7.920
    (-6.41%)
    115.550 USD
    T
    TWLO
    -3.670
    (-3.11%)
    114.330 USD
    UBER
    UBER
    -2.360
    (-2.90%)
    78.910 USD
    ZM
    ZM
    -0.930
    (-1.11%)
    82.510 USD
    المزيد
الأخبار
المقالات

العنوان: Aura Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.